Strata Critical Medical, Inc. (SRTA): M&A transaction — Strata Critical Medical closes Passenger sale to Joby for ~$76M in stock; shifts to medical transport

Strata Critical Medical, Inc.

Completed sale of Passenger business to Joby Aero on Aug 29; received ~$76M in 5.3M Joby shares, plus up to $35M earnout and $10M holdbacks.
Name changed to Strata Critical Medical; Nasdaq tickers become SRTA (common) and SRTAW (warrants).
Melissa Tomkiel and William Heyburn appointed co-CEOs; both join Board; directors Borthwick and Lerer resigned.
Pro forma shows continuing ops net loss of $1.45M for H1 2025 vs $7.24M reported, reflecting Passenger divestiture.
Company issued updated FY2025 financial guidance; see press release Exhibit 99.2 for details.

item 1.01 item 2.01 item 5.02 item 5.03 item 7.01 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Strata Critical Medical, Inc.: Adopted amended bylaws reflecting name change and other governance revisions (effective 2025-08-28).

Change: bylaw amendment
Effective: 2025-08-28

Exact text from the filing

Additionally, on August 28, 2025, the Board approved an amendment to the Company’s Amended and Restated Bylaws (as so amended and restated, the “Amended Bylaws”).

View on SEC.gov

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Strata Critical Medical, Inc.: Amended charter to change company name to Strata Critical Medical, Inc (effective 2025-08-28).

Change: charter amendment
Effective: 2025-08-28

Exact text from the filing

On August 28, 2025, Board approved an amendment to the Company’s Second Amended Restated Certificate of Incorporation, as amended (the “Charter”), to change the Company’s name to Strata Critical Medical, Inc.

View on SEC.gov

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

Strata Critical Medical, Inc. completed a disposition involving Joby Aero, Inc. for approximately $76.0 million (closed 2025-08-29).

Action: disposition
Counterparty: Joby Aero, Inc.
Consideration: approximately $76.0 million
Closing: 2025-08-29

Exact text from the filing

of Joby Aviation. The purchase price received by the Company upon the consummation of the transactions contemplated by the Purchase Agreement (the “Closing”) was approximately $76.0 million (assuming the closing price per share of $14.27 of Joby Aviation’s common stock as of August 28, 2025), after giving effect to pre-Closing adjustments and indemnity holdbacks

View on SEC.gov

Browse all governance changes →

Strata Critical Medical, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-25-085185

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.